| CAS No. | 91775-62-1 |
| Molecular Formula | C7H14BrN3O |
| Molecular Weight | 236.11 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including 3-bromo-8-methoxyimidazo[1,2-a]pyrazine.
CATO supplies 3-bromo-8-methoxyimidazo[1,2-a]pyrazine (CAS 91775-62-1), a certified reference material (molecular formula C7H14BrN3O, MW 236.11 g/mol) for analytical method development and quality control.
Based on its molecular formula C7H14BrN3O, 3-bromo-8-methoxyimidazo[1,2-a]pyrazine contains an amide group, a hydroxyl group, an ether linkage, bromine substitution; these features give the compound characteristic functional-group stretching vibrations in infrared spectroscopy. The molecular weight of 236.11 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
CATO manufactures 3-bromo-8-methoxyimidazo[1,2-a]pyrazine under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
| Molecular Formula | C7H14BrN3O |
| Molecular Weight | 236.11 g/mol |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 2.0 |
| CAS Registry Year (est.) | 1983 |
| Halogen Content | Br-containing |
| Nitrogen Atoms | 3 |